Protara Therapeutics, Inc. — Director's Dealing 2016

Jun 14, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROTEON THERAPEUTICS INC (PRTO)
CIK: 0001359931
Period of Report: 2016-06-09

Reporting Person: BOHLIN GAREN G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-09	Stock Option (Right to Buy)	$5.90	A	6666	Acquired	2026-06-08	Common Stock, $0.001 par value (6666)	Direct

Footnotes

F1: The options were granted on June 9, 2016 and the shares underlying this option will vest 100% at the earlier of (i) June 9, 2017 and (ii) the Issuer's next annual meeting of stockholders.